By George Glover
Celanese stock was tanking on Tuesday after the chemicals manufacturer said it was expecting demand to weaken in most of its key markets, overshadowing a second-quarter earnings beat.
Shares tumbled 20% to $37.81 in early trading. The S&P 500 was 0.6% higher.
The selloff came after Celanese reported adjusted earnings of $1.44 a share for the three months ended June 30, as sales climbed 6% from a year ago to $2.53 billion. Analysts were expecting earnings of $1.40 a share on sales of $2.53 billion, according to a FactSet poll.
Overshadowing the earnings beat was some rough guidance. Celanese expects third-quarter earnings of between $1.10 and $1.40 a share. The midpoint of those figures is way below the $1.68 a share analysts had been forecasting.
"In this low-demand environment that remains uncertain, we will continue to emphasize cash flow," President and CEO Scott Richardson said.
It has been a rough year so far for the chemicals industry, with manufacturers battling an uptick in energy costs as well as weak demand in Europe. Celanese shares are down 31% in 2025, compared with an 8.4% rise for the S&P 500.
Write to George Glover at george.glover@dowjones.com
This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
August 12, 2025 10:01 ET (14:01 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.